Loading clinical trials...
Loading clinical trials...
Comparison of the Efficacy of Oral Contraceptive, Progesterone, and Inositol Use in Regulating Menstrual Cycles in Patients With Polycystic Ovary Syndrome (PCOS)
Conditions
Interventions
Combined Oral Contraceptive (Ethinylestradiol 0.03 mg + Drospirenone 3 mg)
Inositol mid-level volume
+1 more
Locations
1
Turkey (Türkiye)
Izmir Bakircay University
Izmir, Menemen, Turkey (Türkiye)
Start Date
December 1, 2025
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
December 18, 2025
NCT07394530
NCT07266259
NCT07129434
NCT06842524
NCT06896981
NCT07480993
Lead Sponsor
Ege University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions